MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Cue Biopharma, Inc.

CUE

#3645
Cue Biopharma, Inc.
0.28
0.00%
Sector:
Base:
Profit Currency:
Daily Range
0.28
0.28
Year Range
0.23
1.25
Daily Change
0.00%
Monthly Change
-26.32%
6 month change
-65.85%
Year Change
-76.47%
Previous Close
0.28
Open
0.28
Bid
Ask
Low
0.28
High
0.28
Volume
6
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CUE
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
CUE
2025.12.19
Cue Biopharma fissa il prezzo dell’offerta pubblica di 10 milioni di dollari a 0,28 dollari per azione
Investing Investing
CUE
2025.12.19
Cue Biopharma prices $10 million public offering at $0.28 per share
Investing Investing
CUE
2025.12.18
Azioni Cue Biopharma crollano dopo l’annuncio di offerta pubblica
Investing Investing
CUE
2025.12.18
Cue Biopharma stock tumbles on public offering announcement
Investing Investing
CUE
2025.12.18
Cue Biopharma launches public offering of common stock and warrants
Investing Investing
CUE
2025.11.18
Cue Biopharma: Citizens riconferma rating Outperform con target di $2,00
Investing Investing
CUE
2025.11.18
Cue Biopharma stock rating reiterated at Market Outperform by Citizens
Investing Investing
CUE
2025.11.13
ImmunoScape ottiene licenza per tecnologia Cue Biopharma per nuova terapia contro il cancro
Investing Investing
CUE
2025.11.13
ImmunoScape licenses Cue Biopharma technology for novel cancer therapy
Investing Investing
CUE
2025.11.13
Gli EPS di Cue Biopharma hanno battuto le aspettative per 0,02$, il fatturato appena sotto le previsioni
Investing Investing
CUE
2025.11.13
Cue Biopharma earnings beat by $0.02, revenue fell short of estimates
Zacks Zacks
CUE
2025.11.12
Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd